Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries... Show more
Ichor Holdings is a leading designer and manufacturer of critical fluid delivery subsystems — gas and chemical delivery systems that control the precise gases and reactive liquids used in semiconductor manufacturing steps such as etch, deposition, cleaning, and chemical-mechanical planarization. The company also supplies precision-machined components, weldments, and surface-treatment technologies to defense, aerospace, and medical markets. This niche positions Ichor as a direct beneficiary of rising capital intensity in advanced chipmaking rather than as a competitor to large equipment makers.
The medium-term thesis centers on vertical integration. Under new leadership, management is raising the share of internally produced components — a metric that exited the most recent quarter near 25% and is targeted to reach roughly 35% by year-end — which supports gross margin and reduces reliance on outside suppliers. Installed manufacturing capacity can support about $2 billion in annual revenue, with room to expand to roughly $3 billion within the existing footprint. That scale provides operating leverage if demand materializes, but it also means the stock's valuation already reflects meaningful growth expectations, leaving limited room for execution missteps.
Quarterly earnings remain the most visible near-term catalyst. Management guided to a steeper second-half ramp, expecting sequential revenue growth above 10% in consecutive quarters and gross margin improving by roughly 100 basis points per quarter. New customer qualifications for machining and welding operations in Malaysia are expanding internal supply, while faster qualification cycles at major customers could accelerate margin gains.
On the analyst front, sentiment has shifted in a telling way. The consensus recommendation is a Strong Buy, with the majority of covering analysts rating the stock a Buy and a minority at Hold. However, the most recent wave of target revisions has been downward — firms including B. Riley, TD Cowen, Stifel, and Freedom Capital trimmed price targets in early November even while maintaining Buy ratings — reflecting the fact that a rapid advance in the share price compressed the remaining upside rather than any deterioration in the underlying growth outlook. Average price targets now cluster in a wide range, generally from the mid-$70s to the low-$90s depending on the data provider, with individual estimates spanning from the $50s to well above $100. This widening dispersion underscores how much of the debate now hinges on whether margin execution and the 2027 revenue ramp can justify current multiples.
Ichor's trajectory is tightly coupled to semiconductor capital-equipment cycles. Demand is currently being propelled by AI-driven investment, the transition to GAA architectures, rising etch and deposition intensity, and an accelerating memory cycle — all areas where the company's fluid delivery systems are heavily used. Sustained AI infrastructure spending and a recovery in NAND and high-bandwidth memory would reinforce the revenue ramp into 2027.
Conversely, the business remains cyclical and exposed to the interest-rate environment that shapes fab (semiconductor fabrication plant) CapEx decisions. Higher-for-longer borrowing costs could temper equipment spending, while any slowdown in AI data-center investment or a memory-market correction would flow quickly through order patterns. Tariff and trade-policy uncertainty also introduces supply-chain and pricing risk given the company's global manufacturing footprint. Management's diversification into commercial space and defense provides a partial buffer against semiconductor cyclicality.
Investors tracking the forward direction of names like ICHR can also turn to Tickeron's Trend Prediction Engine, an AI-powered forecasting tool designed to help traders assess whether a stock, exchange-traded fund (ETF), or other asset may trend bullish, bearish, or sideways over the coming week or month. The engine is built to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a broad universe of tradable instruments, with searchable prediction categories, historical context, and alert-oriented functionality. For those seeking a systematic, data-driven complement to fundamental research, exploring the platform can add a quantitative layer to the decision-making process.
Looking into 2026 and beyond, the investment narrative hinges on whether Ichor can convert a cyclical demand upswing into durable, structurally higher profitability. The company's vertical-integration strategy — expanding internal machining and welding content while rebalancing its footprint across Malaysia and North America — is designed to lift gross margin toward 20% over time and reduce exposure to external supply constraints. If the company reaches its capacity and margin milestones, earnings could scale sharply given the operating leverage embedded in the model.
Longer-term themes include deepening AI-related demand across advanced logic and memory, the migration to next-generation transistor and packaging technologies, and the gradual build-out of the commercial space segment. Competitive threats from other subsystem suppliers and the persistent risk of customer concentration remain structural considerations, as do capital-allocation choices now that the company has bolstered its cash position through an equity offering. Consensus financial estimates point to meaningful revenue and earnings growth into 2027, but valuations already incorporate a considerable share of that optimism, making disciplined margin execution the pivotal variable for sustaining investor confidence.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, ICHR has been closely correlated with UCTT. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICHR jumps, then UCTT could also see price increases.
| Ticker / NAME | Correlation To ICHR | 1D Price Change % | ||
|---|---|---|---|---|
| ICHR | 100% | +2.38% | ||
| UCTT - ICHR | 86% Closely correlated | +1.79% | ||
| AMAT - ICHR | 75% Closely correlated | +0.53% | ||
| COHU - ICHR | 72% Closely correlated | +0.39% | ||
| ENTG - ICHR | 72% Closely correlated | -1.06% | ||
| AMKR - ICHR | 71% Closely correlated | -1.51% | ||
More | ||||
| Ticker / NAME | Correlation To ICHR | 1D Price Change % |
|---|---|---|
| ICHR | 100% | +2.38% |
| Electronic Production Equipment industry (30 stocks) | 80% Closely correlated | +6.10% |
| ICHR industry (17 stocks) | 80% Closely correlated | +7.15% |
a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment
Industry ElectronicProductionEquipment
ICHR moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend. In 28 of 32 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 88%.
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ICHR as a result. In 69 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for ICHR turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 41 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
The 10-day moving average for ICHR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.
The 50-day moving average for ICHR moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ICHR entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ICHR's RSI Oscillator exited the oversold zone, 25 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 60 cases where ICHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
Following a +13.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in 252 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
ICHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.340) is normal, around the industry mean (5.670). P/E Ratio (-26.466) is within average values for comparable stocks, (68.795). Projected Growth (PEG Ratio) (0.251) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.761) is also within normal values, averaging (27.897).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ICHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.